Free Trial Information
BioCentury | Jun 13, 2019
Emerging Company Profile

Gracell: Speeding up CAR T cells

...Funds raised: About $100 million Investors: Temasek, Lilly Asia Ventures, Kington Capital, King Star Capital, Chengdu Miaoji...
Read More
BioCentury | Mar 2, 2019
Company News

Emerging company roundup: Anthos, Maze, Oyster Point

...Biotechnologies Co. Ltd. (Suzhou, China) Monday. Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji...
Read More
BioCentury | Feb 28, 2019
Financial News

Gracell raises $85M series B to advance cell therapies

...Suzhou, China) that closed Feb. 25. Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji...
Read More
BioCentury | Feb 25, 2019
Financial News

Gracell raises $85M series B to advance cell therapies

...Gracell Biotechnologies Co. Ltd. (Suzhou, China). Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji...
Read More
Items per page:
1 - 4 of 4
BioCentury | Jun 13, 2019
Emerging Company Profile

Gracell: Speeding up CAR T cells

...Funds raised: About $100 million Investors: Temasek, Lilly Asia Ventures, Kington Capital, King Star Capital, Chengdu Miaoji...
Read More
BioCentury | Mar 2, 2019
Company News

Emerging company roundup: Anthos, Maze, Oyster Point

...Biotechnologies Co. Ltd. (Suzhou, China) Monday. Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji...
Read More
BioCentury | Feb 28, 2019
Financial News

Gracell raises $85M series B to advance cell therapies

...Suzhou, China) that closed Feb. 25. Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji...
Read More
BioCentury | Feb 25, 2019
Financial News

Gracell raises $85M series B to advance cell therapies

...Gracell Biotechnologies Co. Ltd. (Suzhou, China). Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji...
Read More
Items per page:
1 - 4 of 4